Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | Latin America | 2022

Despite the negative impact of the COVID-19 pandemic in the short term, the Latin American IC device market will grow moderately, driven by an expanding CAD patient pool and increasing adoption of premium-priced devices—such as next generation DES, BRS, and intravascular imaging catheters and pressure guidewires—supporting revenues. However, a lack of reimbursement and continuing budgetary constraints among Latin American facilities will inhibit uptake of high-cost products and limit overall market growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional cardiology devices in Argentina, Brazil, Colombia, and Mexico across an 11-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…